EUVIMEDEUVIMED entdecken
Crossref

Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients

Shijia Cheng, Zheng Yan, Hongxia Ma, Yanyan Liu

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05900-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Shijia Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To explore the clinical features, treatment, and prognosis of patients with lymphoma-associated hemophagocytic syndrome (LAHS) in a real-world clinical setting. We retrospectively examined LAHS patients diagnosed at our center between January 2016 and August 2023, focusing primarily on their clinical features, therapeutic approaches, overall response rate (ORR), and overall survival (OS). A combination of univariate and multivariate analyses was conducted to identify potential prognostic factors. A total of 86 patients diagnosed with LAHS were included to evaluate clinical characteristics and prognostic factors. Patients with T/NK cell lymphoma had a higher probability of developing hemophagocytic syndrome (HPS) during the clinical process than those with B cell lymphoma. The median survival time was 55 days for all patients, and 47 and 81 days for the T/NK cell LAHS and B cell LAHS cohorts, respectively (P = 0.025). Among the patients evaluated, the ORR was 42.2%. Patients starting with anti-lymphoma treatment had a better, albeit not significant, ORR than those beginning with anti-HPS treatment. In the univariate analysis, T/NK cell LAHS (P = 0.027), HPS onset at relapse (P = 0.036), higher baseline plasma EBV-DNA levels (> 4,000 copies/mL, P = 0.034), and treatments including cytokine adsorption and ruxolitinib (P < 0.001 and P = 0.017, respectively) were potentially associated with worse OS, while corticosteroid therapy benefited OS. In the multivariate analysis, T/NK cell LAHS (adjusted hazard ratio (aHR) = 2.007), cytokine adsorption therapy (aHR = 4.547), and corticosteroid therapy (aHR = 0.118) were independently associated with mortality. T/NK cell lymphoma was the main cause of LAHS and carried a worse prognosis. Whether anti-lymphoma or anti-HPS treatment should start first still requires prospective studies with larger sample sizes. The key point in controlling HPS is to block the cytokine storm promptly. Corticosteroid therapy is both effective and accessible and should be used early and in sufficient quantities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdultAged, 80 and overLymphoma, B-CellSurvival RatePrognosisYoung AdultAdolescentLymphoma, T-Cell

Stichwörter der Autor:innen

Clinical featureHemophagocytic syndromeLymphomaPrognosis

Autor:innen und Institutionen

  • Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.
  • Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou, Henan, 450099, China.
  • Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China. yyliu@zzu.edu.cn.

Zitieren

APA

Cheng, S., Yan, Z., Ma, H., & Liu, Y. (2024). Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients. Annals of Hematology. https://doi.org/10.1007/s00277-024-05900-y

Vancouver

Cheng S, Yan Z, Ma H, Liu Y. Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients. Annals of Hematology. 2024. doi:10.1007/s00277-024-05900-y

BibTeX
@article{Cheng2024,
  author = {Cheng, Shijia and Yan, Zheng and Ma, Hongxia and Liu, Yanyan},
  title = {Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05900-y}
}
Kostenlos starten →